Lipid peroxidation and antioxidants as biomarkers of tissue damage

Clinical Chemistry

Volumn 41, Issue 12 SUPPL., 1995, Pages 1819-1828

  Gutteridge, John M C ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

ceruloplasmin; hydroxyl radicals; oxidative stress; reactive iron; superoxide dismutase; vitamin E

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; AMINO ACID OXIDASE; ANTIOXIDANT; ASCORBIC ACID; BILIRUBIN; BIOLOGICAL MARKER; CATALASE; CERULOPLASMIN; CHOLESTEROL; CYTOCHROME C; FERROUS ION; GLUCOSE OXIDASE; GLUTATHIONE PEROXIDASE; HAPTOGLOBIN; HEAT SHOCK PROTEIN; HEMOPEXIN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYPOCHLOROUS ACID; IRON; LIPID; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSFERRIN; UBIQUINONE; UNINDEXED DRUG; URATE OXIDASE;

AIR; ATHEROSCLEROSIS; CONFERENCE PAPER; ELECTRON; GENE; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; TISSUE INJURY;

EID: 0028792111     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/41.12.1819     Document Type: Conference Paper

References (56)

1. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine, 2nd ed. Oxford, UK: Oxford University Press, 1989: 543pp.
2. McCord JM, Fridovich I. Superoxide dismutase, an enzymic function of erythrocuprein (hemocuprein). J Biol Chem 1969;244: 6049-55.
3. Fenton HJH. Oxidation of tartaric acid in presence of iron. J Chem Soc 1984;65:899-909.
4. Moncada S, Higgs EA. Endogenous nitric oxide: physiology, pathology and clinical relevance [Review]. Eur J Clin Invest 1991;21:361-74.
5. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990;87:1620-4.
6. -. Implications for the action of endothelium-derived relaxing factor (EDRF). Free Radic Res Commun 1990;10:221-6.
7. Candeias LP, Patel KB, Stratford MRL, Wardman P. Free hydroxyl radicals are formed as reaction between the neutrophilderived species superoxide and hypochlorous acid. FEBS Lett 1993;333:151-3.
8. Candeias LP, Stratford MRL, Wardman P. Formation of hydroxyl radicals on reaction of hypochlorous acid with ferrocyanide, a model iron(II) complex. Free Radic Res Commun 1994;20: 241-9.
9. Farmer EH, Sutton DA. The course of autoxidation reactions in poly-isoprenes and allied compounds: V. Observations on fish-oil acids. J Chem Soc 1943;24:122-5.
10. Gutteridge JMC, Halliwell B. The measurement and mechanisms of lipid peroxidation in biological systems. Trends Biochem Sci 1990;15:129-35.
11. Gutteridge JMC. Lipid peroxidation: some problems and concepts. In: Halliwell B, ed. Oxygen radicals and tissue injury. Bethesda, MD: FASEB, 1988:9-19.
12. Gutteridge JMC, Kerry PJ. Detection by fluorescence of peroxides and carbonyls in samples of arachidonic acid. Br J Pharmacol 1982;76:459-61.
13. Gutteridge JMC. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 1986;20:291-5.
14. Gutteridge JMC, Beard APC, Quinlan GJ. Superoxide-dependent lipid peroxidation: problems with the use of catalase as a specific probe for Fenton-driven hydroxyl radicals. Biochem Biophys Res Commun 1983;117:901-7.
15. Gutteridge JMC, Paterson SK, Segal AW, Halliwell B. Inhibition of lipid peroxidation by the iron-binding protein lactoferrin. Biochem J 1981;199:259-61.
16. Gutteridge JMC. Free radicals in disease processes: a compilation of cause and consequence [Review]. Free Radic Res Commun 1993;19:141-58.
17. Rawls HR, Van Santen PJ. Singlet oxygen: a possible source of the original hydroperoxides in fatty acids. Ann N Y Acad Sci 1970;171:135-7.
18. - with unsaturated fatty acids. J Biol Chem 1983;258:4759-61.
19. Gutteridge JMC. The role of superoxide and hydroxyl radicals in phospholipid peroxidation catalysed by iron salts. FEBS Lett 1982;150:454-8.
20. Borg DC. Applications of electron spin resonance in biology. In: Pryor WA, ed. Free radicals in biology, Vol. 1. New York: Academic Press, 1976:69-147.
21. Garnier-Suillerot A, Tose L, Paniago E. Kinetic and mechanism of vesicle lipoperoxide decomposition by Fe(II). Biochim Biophys Acta 1984;794:307-12.
22. Hardwick TJ. The rate constant of the reaction between ferrous ions and hydrogen peroxide in acid solution. Can J Chem 1957;35:428-36.
23. Davies KJA. Protein damage and degradation by oxygen radicals: 1. General aspects. J Biol Chem 1987;262:9895-901.
24. Wolff S, Dean RT. Fragmentation of proteins by free radicals and its effect on their susceptibility to enzymic hydrolysis. Biochem J 1986;234:399-403.
25. Kuehl FA, Egan RW. Prostaglandins, arachidonic acid and inflammation. Science 1980;210:978-84.
26. Hochstein P, Ernster L. ADP-activated lipid peroxidation coupled to the TPNH oxidase system of microsomes. Biochem Biophys Res Commun 1963;12:388-94.
27. Esterbauer H, Schaur RJ, Zollner J. Chemistry and biochemistry of 4-hydroxynonenal malondialdehyde and related aldehydes [Review]. Free Radic Biol Med 1991;11:82-128.
28. Galliard T. Lipolytic and lipoxygenase enzymes in plants and their action in wounded tissue. In: Kahl G, ed. Biochemistry of wounded plant tissue. Berlin: de Gruyter, 1978:156-201.
29. Stocks J, Gutteridge JMC, Sharp RJ, Dormandy TL. Assay using brain homogenate for measuring the antioxidant activity of biological fluids. Clin Sci Mol Med 1974;47:215-22.
30. Halliwell B, Gutteridge JMC. Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet 1984;i: 1396-8.
31. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site of macrophages of acetylated low density lipoprotein producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 76:333-7.
32. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
33. Esterbauer H, Jurgens G, Quehenberger O, Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 1987;28:495-509.
34. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultured epidemiology. Am J Clin Nutr 1991; 53(Suppl):326-34.
35. Gey KF, Puska P. Plasma vitamin E and A inversely correlated to mortality from ischemic heart disease in cross-cultured epidemiology. Ann N Y Acad Sci 1989;570:268-82.
36. Sullivan JL. The iron paradigm of heart disease [Editorial]. Am Heart J 1989;117:1177-88.
37. Reunanen A, Knekt R, Ritva-Kaarina A. Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am J Epidemiol 1992;136:1082-90.
38. Gutteridge JMC, Halliwell B. The antioxidant problems of extracellular fluids. In: Chow CK, ed. Cellular antioxidant defense mechanisms, Vol 2. Boca Raton, FL: CRC Press, 1988:1-23.
39. Fridovich I. Superoxide dismutases. Adv Enzymol 1974;41: 35-48.
40. Jacobs A. Low molecular weight intracellular iron transport compounds. Blood 1970;50:433-9.
41. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59:527-605.
42. Halliwell B, Gutteridge JMC. The definition and measurement of antioxidants in biological systems. Free Radic Biol Med 1995;18:125-6.
43. Burton GW, Joyce A, Ingold KV. First proof that vitamin E is a major lipid soluble, chain-breaking antioxidant in human blood plasma. Lancet 1982;ii:327-8.
44. Stocks J, Gutteridge JMC, Sharp RJ, Dormandy TL. The inhibition of lipid autoxidation by human serum and its relationship to serum proteins and alpha-tocopherol. Clin Sci Mol Med 1974;47:223-33.
45. Marklund SL, Holme E, Hellner L. Superoxide dismutase in extracellular fluids. Clin Chim Acta 1982;125:41-51.
46. Maddipati KR, Marnett LJ. Characterization of the major hydroperoxide-reducing activity of human plasma: purificaition and properties of a selenium-dependent glutathione peroxidase. J Biol Chem 1987;262:17398-403.
47. Halliwell B, Gutteridge JMC. Oxygen free radicals in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986;246:501-14.
48. Saran M, Bors W. Oxygen radicals acting as chemical messengers: a hypothesis. Free Radic Res Commun 1989;7:213-20.
49. Gutteridge JMC. The antioxidant activity of haptoglobin towards haemoglobin stimulated lipid peroxidation. Biochim Biophys Acta 1987;917:219-23.
50. Gutteridge JMC, Smith A. Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem J 1988; 256:861-5.
51. Gutteridge JMC, Stocks J. Ceruloplasmin: physiological and pathological perspectives. CRC Crit Rev Clin Lab Sci 1981;14: 257-329.
52. Gutteridge JMC, Richmond R, Halliwell B. Oxygen free radicals and lipid peroxidation: inhibition by the protein caeruloplasmin. FEBS Lett 1980;112:269-72.
53. Gutteridge JMC. Antioxidant properties of caeruloplasmin towards iron and copper dependent oxygen radical formation. FEBS Lett 1983;157:30-40.
54. Bannister JV, Bannister WH, Hill HAO, Mahood JF, Willson RL, Wolfenden BS. Does caeruloplasmin dismute superoxide? No. FEBS Lett 1980;118:127-9.
55. Calabrese L, Carbonaro M. An e.p.r. study of the nonequivalence of the copper sites of caeruloplasmin. Biochem J 1986;238:291-5.
56. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988;85:9748-52.